Simulations Plus Investors

Simulations Plus is a developer of Absorption, Distribution, Metabolism, Excretion and Toxicity (ADMET).

Funding Status: IPO
Headquarters: United States
Acquisitions Number: 4
Founded Date: 1996-01-01
Employee Number: 51-100
Last Funding Type: Grant
Total Funding: 1700000.0
Estimated Revenue: $10M to $50M
Industry: Early Drug Development
Investors Number: 2.0
Technology: Biotechnology, Computer, Data Mining, Enterprise Software, Information Technology, Life Science
Last Funding Date: 2022-03-29